FI62281C - Foerfarande foer framstaellning av antidepressivt verksamma 4-minoamfetaminderivat - Google Patents
Foerfarande foer framstaellning av antidepressivt verksamma 4-minoamfetaminderivat Download PDFInfo
- Publication number
- FI62281C FI62281C FI2576/74A FI257674A FI62281C FI 62281 C FI62281 C FI 62281C FI 2576/74 A FI2576/74 A FI 2576/74A FI 257674 A FI257674 A FI 257674A FI 62281 C FI62281 C FI 62281C
- Authority
- FI
- Finland
- Prior art keywords
- tai
- compound
- ether
- jossa
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7312001A SE382047B (sv) | 1973-09-04 | 1973-09-04 | Forfarande for framstellning av 4-aminoamfetaminderivat |
| SE7312002 | 1973-09-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI257674A FI257674A (de) | 1975-03-05 |
| FI62281B FI62281B (fi) | 1982-08-31 |
| FI62281C true FI62281C (fi) | 1982-12-10 |
Family
ID=20318423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI2576/74A FI62281C (fi) | 1973-09-04 | 1974-09-03 | Foerfarande foer framstaellning av antidepressivt verksamma 4-minoamfetaminderivat |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3996381A (de) |
| JP (1) | JPS5835177B2 (de) |
| AT (1) | AT336566B (de) |
| BE (1) | BE819515A (de) |
| CA (1) | CA1051436A (de) |
| CH (2) | CH603547A5 (de) |
| DE (1) | DE2440734C2 (de) |
| DK (1) | DK139716B (de) |
| FI (1) | FI62281C (de) |
| FR (1) | FR2242079B1 (de) |
| GB (1) | GB1461667A (de) |
| HK (1) | HK75778A (de) |
| IE (1) | IE40514B1 (de) |
| LU (1) | LU70852A1 (de) |
| NL (1) | NL7411753A (de) |
| NO (2) | NO139408C (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
| US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
| US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
| US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
| CA2427388C (en) * | 2000-11-01 | 2011-12-20 | Sention, Inc. | Pharmaceutical compositions and uses for improving memory and learning impairments |
| US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3117160A (en) * | 1961-07-27 | 1964-01-07 | Pfizer & Co C | Aralkylamines |
| US3496195A (en) * | 1966-05-11 | 1970-02-17 | Chinoin Gyogyszer Es Vegyeszet | D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts |
-
1974
- 1974-08-14 US US05/497,295 patent/US3996381A/en not_active Expired - Lifetime
- 1974-08-24 DE DE2440734A patent/DE2440734C2/de not_active Expired
- 1974-08-30 AT AT702574A patent/AT336566B/de not_active IP Right Cessation
- 1974-09-03 CH CH1173577A patent/CH603547A5/xx not_active IP Right Cessation
- 1974-09-03 FI FI2576/74A patent/FI62281C/fi active
- 1974-09-03 CA CA208,356A patent/CA1051436A/en not_active Expired
- 1974-09-03 CH CH1195874A patent/CH599106A5/xx not_active IP Right Cessation
- 1974-09-03 FR FR7429970A patent/FR2242079B1/fr not_active Expired
- 1974-09-03 IE IE1824/74A patent/IE40514B1/xx unknown
- 1974-09-03 JP JP49100618A patent/JPS5835177B2/ja not_active Expired
- 1974-09-03 DK DK464774AA patent/DK139716B/da not_active IP Right Cessation
- 1974-09-03 GB GB3849974A patent/GB1461667A/en not_active Expired
- 1974-09-04 NL NL7411753A patent/NL7411753A/xx not_active Application Discontinuation
- 1974-09-04 LU LU70852A patent/LU70852A1/xx unknown
- 1974-09-04 BE BE148180A patent/BE819515A/xx not_active IP Right Cessation
- 1974-09-04 NO NO743177A patent/NO139408C/no unknown
-
1978
- 1978-12-28 HK HK757/78A patent/HK75778A/xx unknown
-
1979
- 1979-05-04 NO NO791507A patent/NO142624C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7283374A (en) | 1976-03-04 |
| IE40514L (en) | 1975-03-04 |
| DE2440734A1 (de) | 1975-03-13 |
| JPS5835177B2 (ja) | 1983-08-01 |
| IE40514B1 (en) | 1979-06-20 |
| DK464774A (de) | 1975-05-05 |
| NO142624C (no) | 1980-09-17 |
| NO139408B (no) | 1978-11-27 |
| CH603547A5 (de) | 1978-08-31 |
| NO743177L (de) | 1975-04-01 |
| NO142624B (no) | 1980-06-09 |
| US3996381A (en) | 1976-12-07 |
| FI62281B (fi) | 1982-08-31 |
| CA1051436A (en) | 1979-03-27 |
| HK75778A (en) | 1979-01-05 |
| LU70852A1 (de) | 1975-06-11 |
| JPS5050329A (de) | 1975-05-06 |
| CH599106A5 (de) | 1978-05-12 |
| NO139408C (no) | 1979-03-07 |
| GB1461667A (en) | 1977-01-19 |
| NO791507L (no) | 1975-03-05 |
| FI257674A (de) | 1975-03-05 |
| NL7411753A (nl) | 1975-03-06 |
| FR2242079A1 (de) | 1975-03-28 |
| AT336566B (de) | 1977-05-10 |
| DK139716C (de) | 1979-09-17 |
| DK139716B (da) | 1979-04-02 |
| FR2242079B1 (de) | 1978-07-21 |
| DE2440734C2 (de) | 1985-01-24 |
| ATA702574A (de) | 1976-09-15 |
| BE819515A (fr) | 1975-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101346375B (zh) | 调节门离子通道用组合物和方法 | |
| US7655691B2 (en) | Indole compounds useful as serotonin selective agents | |
| US20070299079A1 (en) | 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM | |
| US20090239874A1 (en) | Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them | |
| JPH09291034A (ja) | 縮合ピリジン化合物およびその医薬としての用途 | |
| SK106395A3 (en) | Treating and treatment or prevention of mental diseases | |
| DD152935A5 (de) | Substituierte beta-carbolin-3-carbonsaeure-derivate | |
| CN101360738A (zh) | 调节门控离子通道的组合物和方法 | |
| RU2191776C2 (ru) | Эрголиновые производные, способ их получения, фармацевтическая композиция | |
| DE60101323T2 (de) | Tricyclische proteinkinasehemmer | |
| EP1833830A1 (de) | Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel | |
| FI62281C (fi) | Foerfarande foer framstaellning av antidepressivt verksamma 4-minoamfetaminderivat | |
| CA3150465A1 (en) | Fused ring heteroaryl compounds as ripk1 inhibitors | |
| US20150196529A1 (en) | Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs | |
| EP2166852B1 (de) | Therapeutische pyrazolochinolinderivate | |
| US20090054433A1 (en) | Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist | |
| NO313963B1 (no) | 4-okso-3,5-dihydro-4H-pyridazino[4,5-b]indol-1-acetamid- derivater, medikamenter og farmasöytiske preparater | |
| PT85936B (pt) | Processo para a preparacao de 4,5-di-hidro- e 4,5,6,7-tetra-hidro-pirazolo {-1-5-a}-pirimidinas | |
| PT865442E (pt) | Imidazo¬1,2-a|quinoxalin-4-aminas activas como antagonistas de adenosina processo para a sua preparacao e suas composicoes farmaceuticas | |
| CZ9394A3 (en) | 9H-IMIDAZO/1,2-a/BENZIMIDAZOL-3-ACETAMIDO DERIVATIVES, PROCESS OF THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS IN WHICH THEY ARE COMPRISED | |
| WO2008084491A1 (en) | 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands | |
| DE602005001434T2 (de) | Arylpiperazinderivate als selektive Liganden für den Dopamin D3 Rezeptor | |
| JP2807633B2 (ja) | Ｎ−（ピリジニル）−ｉｈ−インドール−１−アミンを含有する強迫疾患治療剤 | |
| CN102112469A (zh) | 神经元nAChR的安静减敏剂及其使用方法 | |
| WO2007138611A1 (en) | 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands |